Vor Biopharma Inc. (VOR) is a biological products, (no diagnostic substances) company, listed on the Nasdaq. With a market capitalization of $660 million, Vor Biopharma Inc. is a small-cap company. The stock currently trades at $15.90, up 2.98% today, with a 52-week range of $2.62–$65.80.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.70 | $-1.70 | +2.9% | |
| 2023 | $-1.75 | $-1.75 | +24.9% | |
| 2022 | $-2.33 | $-2.33 | — | |
| 2021 | — | — | — |